S

Syngene International Ltd

Labs & Life Sciences ServicesSmallcap

About the company

Syngene International Limited is a contract research company. It is engaged in providing contract research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies.

Performance

Stock
Loading Stock value

Analyst Ratings and Key Metrics

Based on 6 analysts offering recommendations for Syngene International Ltd

67%

Buy

16%

Hold

17%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio33.2835.79
PB Ratio3.495.65
Dividend Yield0.30%0.60%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions